A phase 1–2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]

BACKGROUND: The prognosis of patients suffering from WHO grade 3 and 4 astrocytic glioma remains poor despite surgery, radiation therapy and the use of current chemotherapy regimen. Indeed, the median survival of glioblastoma multiforme (WHO grade 4) patients is at best 14.6 month with only 26.5 per...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Robe, Pierre A, Martin, Didier, Albert, Adelin, Deprez, Manuel, Chariot, Alain, Bours, Vincent
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2006
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1368982/
https://ncbi.nlm.nih.gov/pubmed/16448552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-6-29
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados